- 1. Immature
- [In an early period of life or development or growth. ( NCI )] (UMLS (NCI) C0205252) =Temporal Concept
| - 51. Immune System and Related Disorders
- (UMLS (NCI) C1334156) Immunodeficiency and Immunosuppression Disorders =Disease or Syndrome ;
|
- 2. immature animal
- [animal that has not reached adult age; animal that is not fully grown or developed. ( CSP )] (UMLS (CSP) C0596750) =Organism Attribute ;
=animal age group;
=larva;
juvenile animal;
infant animal;
| - 52. Immune System Finding
- (UMLS (NCI) C1291764) =Finding ;
|
- 3. Immature Gastric Teratoma
- (UMLS (NCI) C1334151) Malignant Gastric Teratoma;
Malignant Teratoma of Stomach;
Malignant Teratoma of the Stomach =Neoplastic Process ;
| - 53. immune system surgery
- [ ] (UMLS (CSP) C1285315) =Therapeutic or Preventive Procedure
|
- 4. Immature Germ Cell Teratoma of Ovary
- (UMLS (NCI) C0346182) =Neoplastic Process
| - 54. immune system tolerance
- [The failure of the immune system to respond to an antigen that previously caused an immune response. ( NCI )] (UMLS (NCI) C0020963) =Pathologic Function
|
- 5. Immature Granulocyte
- [A not-yet-mature white blood cell with staining granules in its cytoplasm. The staining granules may be neutrophilic, acidophilic, or basophilic in character. There are indications that an immature granulocyte count is a better measure of infection and sepsis than a total white blood cell count and comparable to absolute neutrophil count. ( NCI )] (UMLS (NCI) C1317395) =Cell; ;
| - 55. IMMUNE THROMBOCYT PURPRA
- (UMLS (ICD9CM) C0398650) =Disease or Syndrome ;
|
- 6. Immature Granulocytes in Peripheral Blood Increased
- (UMLS (NCI) C1334152) =Laboratory or Test Result ;
| - 56. immune tolerance/unresponsiveness
- [failure to respond to contact with antigen; may be specific for a given antigen (tolerance) or generalized to many antigens, as in immunodeficiency states. ( CSP )] (UMLS (CSP) C0178709) =Disease or Syndrome =immunity;
immune modulation;
immunopathology;
=immunosuppression;
anergy;
oral tolerance;
|
- 7. Immature Granulocytic Sarcoma
- [A granulocytic sarcoma composed of myeloblasts and promyelocytes (WHO 2001). —2003 ( NCI )] (UMLS (NCI) C1334153) =Neoplastic Process ;
| - 57. immunity
- [nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. ( CSP )] (UMLS (CSP) C0020964) =Physiologic Function =Immunology;
=antigen antibody reaction;
Autoimmune Status;
Cell Mediated Immunity;
Humoral Immunity;
anamnestic reaction;
bactericidal immunity;
cross immunity;
immune tolerance/unresponsiveness;
cell mediated cytotoxicity;
|
- 8. Immature Mediastinal Teratoma
- (UMLS (NCI) C0349663) =Neoplastic Process
| - 58. immunization
- [deliberate induction of host immunity. ( CSP )] (UMLS (CSP) C0020971) =Therapeutic or Preventive Procedure ;
=communicable disease control;
chemotherapy;
immunologic technique;
Immunologically Directed Therapy =Passive Immunization;
Active Immunization;
hyperimmunization;
Booster Immunization;
Initial Immunization;
|
- 9. Immature Monocyte
- [A cell derived from a myeloid stem cell. It is the representation of one stage of monocyte development. ( NCI )] (UMLS (NCI) C1317543) =Cell; ;
| - 59. immunization
- [A technique used to cause an immune response that results in resistance to a specific disease, especially an infectious disease. ( NCI )] (UMLS (NCI) C1368825) =Therapeutic or Preventive Procedure
|
- 10. Immature Teratoma
- (UMLS (NCI) C0334520) =Neoplastic Process
| - 60. immunization category
- [ Definition:All information pertaining to a patient's vaccination records. ( HL7V3.0 )] (UMLS (HL7) C1698056) =Classification ;
=ActCode;
|
- 11. Immature Teratoma of Testis
- (UMLS (NCI) C1334154) Immature Teratoma of the Testis;
Immature Testicular Teratoma;
Malignant Teratoma of Testis;
Malignant Teratoma of the Testis;
Malignant Testicular Teratoma;
Testicular Immature Teratoma;
Testicular Malignant Teratoma =Neoplastic Process ;
| - 61. Immunization Registry Status
- (UMLS (HL7) C1547821) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Inactive - Lost to follow-up (cancel contract);
Inactive - Moved or gone elsewhere (cancel contract);
Inactive - Permanently inactive (Do not reactivate or add new entries to the record);
Other;
Unknown;
Active;
Inactive;
|
- 12. Immediate
- [Query response is immediate. ( HL7V3.0 )] (UMLS (HL7) C1548167) =Idea or Concept =Query priority;
QueryPriority | - 62. Immunization/preventive medication
- (UMLS (ICPC) C0497105) (Immunization/preventive medication; txertaketak/aurrezaintzako medikazioa; Vacc/forebyggende medicinering; Immunisatie/preventieve medicatie; ROKOTUS/ ENNALTAEHKAISEVA LAAKITYS; Vaccination/medication prevent; Impfung/praeventive Medikation; (108); oltas/preventiv gyogyszereles; Immunizzaz/somm prevent farmaci; FOREBYGGENDE VAKSINERING/MEDIKASJ; Vacinacao/medicacao preventiva; Farmacos/inmunizaciones prevent; IMMUNISERING/PREVENTIV MEDICINERING) Immunization/prevent medication =Therapeutic or Preventive Procedure =Diagnostic and Preventive Procedures Component;
|
- 13. immediate
- [The receiver is required to assume that the sender is blocking and behave appropriately by sending an immediate response. ( HL7V3.0 )] (UMLS (HL7) C1697779) =Intellectual Product =ResponseMode;
| - 63. Immuno International AG
- [Immuno International AG ( HL7V3.0 )] (UMLS (HL7) C1546872) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
VaccineManufacturer |
- 14. Immediate
- [Without delay. ( NCI )] (UMLS (NCI) C0205548) =Temporal Concept =Priority;
ActPriority | - 64. Immuno-U.S., Inc.
- [Immuno-U.S., Inc. ( HL7V3.0 )] (UMLS (HL7) C1546874) =Health Care Related Organization =Manufacturers of Vaccines (code=MVX);
VaccineManufacturer |
- 15. immediate early gene
- [Genes that show rapid and transient expression in the absence of de novo protein synthesis. The term was originally used exclusively for viral genes where immediate-early referred to transcription immediately following virus integration into the host cell. It is also used to describe cellular genes which are expressed immediately after resting cells are stimulated by extracellular signals such as growth factors and neurotransmitters. ( MSH )] (UMLS (CSP) C0206256) =Gene or Genome ;
| - 65. immunoaffinity chromatography
- [affinity chromatography using monoclonal or polyclonal antibodies, or (less commonly) antigens, as the immobilized binding phase. ( CSP )] (UMLS (CSP) C0596751) =Laboratory Procedure ;
=affinity chromatography;
immunologic technique |
- 16. immediate early protein
- [proteins that regulate the expression of genes of other kinetic classes. ( CSP )] (UMLS (CSP) C0206355) =Amino Acid, Peptide, or Protein; Biologically Active Substance =DNA binding protein;
=connective tissue growth factor;
| - 66. immunoassay
- [Immunoassay ( HL7V3.0 )] (UMLS (CSP) C0020980) =Laboratory Procedure ;
=ObservationMethod;
|
- 17. immediate memory
- [temporary storage of information for a few seconds to hours, as opposed to long-term memory which refers to material stored for days, years, or a lifetime. ( CSP )] (UMLS (CSP) C0025265) =Mental Process =memory;
| - 67. Immunoassay, qualitative, multiple step
- [Immunoassay, qualitative, multiple step ( HL7V3.0 )] (UMLS (HL7) C0523399) =Laboratory Procedure =ObservationMethod;
|
- 18. Immediate postpartum manual replacement of inverted uterus
- [ ] (UMLS (ICD9CM) C0490068) =Therapeutic or Preventive Procedure
| - 68. Immunoassay, qualitative, single step
- [Immunoassay, qualitative, single step ( HL7V3.0 )] (UMLS (HL7) C0523401) =Laboratory Procedure =ObservationMethod;
|
- 19. Immerse (Soak) Body Part
- (UMLS (HL7) C0694633) =Functional Concept =drug administration route;
| - 69. Immunoassay, semi-quantitative, multiple step
- [Immunoassay, semi-quantitative, multiple step ( HL7V3.0 )] (UMLS (HL7) C0523400) =Laboratory Procedure =ObservationMethod;
|
- 20. Immersion (soak)
- [Immersion (soak) ( HL7V3.0 )] (UMLS (HL7) C1553215) =Functional Concept =BodySurfaceRoute;
RouteByMethod | - 70. Immunoassay, semi-quantitative, single step
- [Immunoassay, semi-quantitative, single step ( HL7V3.0 )] (UMLS (HL7) C0523402) =Laboratory Procedure =ObservationMethod;
|
- 21. immersion foot
- [A condition of the feet produced by prolonged exposure of the feet to water. Exposure for 48 hours or more to warm water causes tropical immersion foot or warm-water immersion foot common in Vietnam where troops were exposed to prolonged or repeated wading in paddy fields or streams. Trench foot results from prolonged exposure to cold, without actual freezing. It was common in trench warfare during World War I, when soldiers stood, sometimes for hours, in trenches with a few inches of cold water in them. (Andrews' Diseases of the Skin, 8th ed, p27) ( MSH )] (UMLS (CSP) C0020941) =Injury or Poisoning =Foot Diseases;
| - 71. Immunoblastic Diffuse Large B-Cell Lymphoma PTLD
- (UMLS (NCI) C1334157) Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder;
Immunoblastic Lymphoma PTLD;
=Neoplastic Process ;
|
- 22. immigrant
- [person coming into a country of which he or she is not a native for the purpose of setting up residence. ( CSP )] (UMLS (CSP) C0282163) =Population Group =named group;
| - 72. Immunoblastic Lymphoma
- [A diffuse large B-cell lymphoma characterized by the presence of immunoblasts with uniformly round-to-oval nuclei, a prominent nucleolus, and abundant cytoplasm. ( NCI )] (UMLS (NCI) C0079746) =Neoplastic Process =histiocytic lymphoma;
Lymphoma, Diffuse;
High Grade Lymphoma;
|
- 23. immigration
- [ ] (UMLS (CSP) C0020942) =Activity
| - 73. Immunoblastic Lymphoma of the Thyroid
- [A diffuse large B-cell lymphoma variant, primarily involving the thyroid gland. It is composed predominantly of immunoblasts. (NCI05) ( NCI )] (UMLS (NCI) C1336752) Immunoblastic Lymphoma of the Thyroid Gland;
Immunoblastic Lymphoma of Thyroid;
Immunoblastic Lymphoma of Thyroid Gland;
Primary Thyroid Gland Immunoblastic Lymphoma;
Thyroid Gland Immunoblastic Lymphoma;
Thyroid Immunoblastic Lymphoma =Neoplastic Process ;
|
- 24. IMMOBILIZ/WOUND ATTN NEC
- [ ] (UMLS (ICD9CM) C0178032) =Therapeutic or Preventive Procedure
| - 74. immunoblotting
- [Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. ( MSH )] (UMLS (CSP) C0020985) =Laboratory Procedure ;
|
- 25. immobilization of body part
- [render a part of the body incapable of being moved, as by a cast or splint. ( CSP )] (UMLS (CSP) C0020944) =Therapeutic or Preventive Procedure =body movement;
| - 75. Immunochemiluminescence
- [Immunoassay, Chemiluminescent ( HL7V3.0 )] (UMLS (HL7) C1553181) =Laboratory Procedure =ObservationMethod;
|
- 26. immobilized enzyme
- [enzymes which are immobilized on or in a variety of water-soluble or water-insoluble matrices with little or no loss of their catalytic activity; since they can be reused continuously, immobilized enzymes have found wide application in the industrial, medical and research fields. ( CSP )] (UMLS (CSP) C0014444) =Amino Acid, Peptide, or Protein; Enzyme; Indicator, Reagent, or Diagnostic Aid =enzyme;
| - 76. immunochemistry
- [field of chemistry that pertains to immunological phenomena and the study of chemical reactions related to antigen stimulation of tissues; includes physicochemical interactions between antigens and antibodies. ( CSP )] (UMLS (CSP) C0020986) =Biomedical Occupation or Discipline ;
=biochemistry;
|
- 27. immortalized cell
- [ ] (UMLS (CSP) C0178708) =Cell
| - 77. immunocompetence
- [The ability to produce a normal immune response. ( NCI )] (UMLS (NCI) C0020987) =Cell Function ;
|
- 28. ImmTher
- (UMLS (NCI) C0281671) =Organic Chemical; Pharmacologic Substance ;
| - 78. immunocompromised
- [Having a weakened immune system caused by certain diseases or treatments. ( NCI )] (UMLS (NCI) C0085393) =Finding
|
- 29. ImmTher/Indomethacin
- (UMLS (NCI) C0281699) =Therapeutic or Preventive Procedure
| - 79. Immunoconjugate, Ricin
- [A ricin-containing immunotoxin with immunotherapeutic property. Ricin, a plant toxin extracted from castor beans, inhibits protein synthesis via cleaving ribosomal subunit 28S rRNA. Ricin immunoconjugate consists of specific antibody conjugated with the blocked ricin (bR), which has the galactose-binding sites of the B-chain blocked while leaving the ribosome-inactivating ricin A-chain intact, thereby attains cell-type-specific immunotoxins. ( NCI )] (UMLS (NCI) C0280032) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 30. IMMU-4
- (UMLS (NCI) C0217156) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 80. immunocytochemistry
- [application of immunochemical techniques, as histochemical localization of immunoreactive substances using labeled antibodies as reagents, to cytochemistry. ( CSP )] (UMLS (CSP) C0242349) =Laboratory Procedure ;
=Cell/Tissue, Histochemistry;
immunologic technique;
staining;
=fluorescent antibody;
immunoperoxidase;
immunoelectron microscopy |
- 31. Immucyst
- (UMLS (NCI) C0255290) =Organic Chemical; Pharmacologic Substance; Immunologic Factor
| - 81. Immunocytoma, Lymphoplasmacytic Type
- [plasma cell dyscrasia resembling leukemia, with cells of lymphocytic, plasmacytic, or intermediate morphology, that secrete an IgM monoclonal component. ( CSP )] (UMLS (NCI) C0024419) =Neoplastic Process ;
=Lymphoproliferative Disorder;
paraproteinemia;
gammopathy;
Vascular Hemostatic Disorders |
- 32. IMMUNDEF T-CELL DEF NOS
- [ ] (UMLS (ICD9CM) C1608262) Immunodeficiency with predominant T-cell defect, unspecified =Pathologic Function ;
| - 82. IMMUNODEFIC W HYPER-IGM
- [ ] (UMLS (ICD9CM) C0740331) Immunodeficiency with increased IgM =Disease or Syndrome ;
|
- 33. Immune
- [Protected against infectious disease by either specific or non-specific mechanisms. ( NCI )] (UMLS (NCI) C0439662) =Functional Concept
| - 83. Immunodeficiency Associated Burkitt Lymphoma
- (UMLS (NCI) C1334158) Immunodeficiency Associated Burkitt's Lymphoma;
Immunodeficiency Related Burkitt Lymphoma;
Immunodeficiency Related Burkitt's Lymphoma;
Immunodeficiency-Associated Burkitt Lymphoma;
Immunodeficiency-Associated Burkitt's Lymphoma;
Immunodeficiency-Related Burkitt Lymphoma;
Immunodeficiency-Related Burkitt's Lymphoma =Neoplastic Process ;
|
- 34. immune adherence reaction
- [a method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets; reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell. ( CSP )] (UMLS (CSP) C0020947) =Laboratory Procedure =agglutination reaction;
| - 84. Immunodeficiency-Related Disorder
- (UMLS (NCI) C1334159) Immunodepression-Related Disorder;
Immunosuppression-Related Disorder;
=Disease or Syndrome ;
|
- 35. Immune blot
- [Molecular, Immune blot ( HL7V3.0 )] (UMLS (HL7) C1553158) =Laboratory Procedure =ObservationMethod;
| - 85. Immunodeficiency-Related Malignant Neoplasm
- (UMLS (NCI) C1334160) Immunosuppression-Related Cancer;
Immunosuppression-Related Malignancy;
Immunosuppression-Related Malignant Neoplasm =Neoplastic Process ;
|
- 36. Immune Cell Activation
- [Immune Cell Activation involves cell interaction and cell signaling mechanisms that recognize or respond to the presence of foreign antigen and that induce responsive cells of the immune system to synthesize and secrete defensive products, to proliferate, to differentiate, or to attack the sources of foreign antigens. ( NCI )] (UMLS (NCI) C1155000) leukocyte activation;
=Cell Function | - 86. Immunodeficiency-Related Neoplasm
- (UMLS (NCI) C1334161) Immunosuppression-Related Neoplasm =Neoplastic Process ;
|
- 37. immune complex disease
- [group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. ( CSP )] (UMLS (CSP) C0020951) =Disease or Syndrome =autoimmune disease;
Allergic Reaction;
Allergy;
=serum sickness;
Arthus phenomenon;
serum sickness;
HYPERSENSIT ANGIITIS NOS | - 87. immunodeficient mouse model
- [ ] (UMLS (CSP) C0599920) =Mammal ;
|
- 38. Immune Complex Glomerulonephritis
- (UMLS (NCI) C0744421) =Disease or Syndrome
| - 88. Immunodiagnosis
- (UMLS (NCI) C0021052) =Laboratory Procedure ;
|
- 39. immune disorder
- [A disorder resulting from an abnormality in the immune system. — 2003 (NCI) ( NCI )] (UMLS (CSP) C0021053) =Disease or Syndrome ;
=Diseases, Manifestations or Physiologic States;
=autoimmune disease;
blood group incompatibility;
Glomerulonephritis, Membranoproliferative;
Graft Rejection;
autoimmune foreign transplant disease;
Allergic Reaction;
hypoimmunity;
Immunoproliferative Disorders;
Purpura, Thrombocytopenic | - 89. immunodiffusion
- [technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. ( CSP )] (UMLS (CSP) C0017231) =Laboratory Procedure ;
=Immune precipitation;
|
- 40. immune globulin/ZDV
- (UMLS (NCI) C0279261) =Therapeutic or Preventive Procedure
| - 90. immunoelectroadsorption
- [ ] (UMLS (CSP) C0596752) =Laboratory Procedure =immunologic assay;
|
- 41. immune inclusion disease
- [ ] (UMLS (CSP) C0598653) =Disease or Syndrome
| - 91. immunoelectron microscopy
- [microscopy in which the samples are first stained immunocytochemically and then examined using an electron microscope. ( CSP )] (UMLS (CSP) C0079835) =Diagnostic Procedure =electron microscopy;
immunocytochemistry |
- 42. IMMUNE MECHANISM DIS NEC
- (UMLS (ICD9CM) C0398672) =Disease or Syndrome ;
| - 92. Immunoelectrophoresis
- [technique that combines protein electrophoresis and double immunodiffusion: in this procedure proteins are first separated by gel electrophoresis, then made visible by immunodiffusion of specific antibodies; a distinct elliptical precipitin arc results for each protein detectable by the antisera. ( CSP )] (UMLS (HL7) C0020997) =Laboratory Procedure ;
=electrophoresis;
immunologic technique;
ObservationMethod;
|
- 43. immune modulation
- [various processes by which antibodies may regulate immune responses; at a simple level, secreted antibody neutralizes the antigen with which it reacts thus preventing further antigenic stimulation of the antibody producing clone; at a more complex level, anti-idiotype antibodies can be shown to develop against the first antibodies in some cases and perhaps further anti-idiotype antibodies against them; this is the major concept of the immunological network theory. ( CSP )] (UMLS (CSP) C0678889) =Organism Function ;
=Immunology;
=anamnestic reaction;
immune tolerance/unresponsiveness;
antigen presentation;
| - 93. Immunoenzyme Technique
- [Immunologic technique based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens (From MESH 2001). ( NCI )] (UMLS (NCI) C0021002) =Laboratory Procedure ;
|
- 44. immune phagocytosis
- [ ] (UMLS (CSP) C0301899) =Cell Function ;
| - 94. Immunofixation
- [An enhancement of immunoelectrophoresis in which a series of post-electrophoretic gel slabs are layered with cellulose-acetate gels saturated with specific antibodies. The resulting antigen-antibody complexes fixed on the second gel may then be stained, allowing sensitive and specific qualitative visual identification of paraproteins by electrophoretic position. It can be used to identify specific proteins in the blood or urine. It has greatest application in the identification and monitoring of monoclonal proteins that are produced in conditions like Waldenstom's macroglobulinaemia and multiple myeloma. ( NCI )] (UMLS (NCI) C0430292) =Laboratory Procedure
|
- 45. Immune precipitation
- [serologic tests in which a positive reaction manifested by visible precipitation occurs when a soluble antigen reacts with its antibody. ( CSP )] (UMLS (HL7) C0021069) =Laboratory Procedure ;
=serology/serodiagnosis;
ObservationMethod =immunodiffusion;
ChIP;
| - 95. Immunofixation electrophoresis (IFE)
- [Electrophoresis, Immunofixation ( HL7V3.0 )] (UMLS (HL7) C1611269) =Laboratory Procedure ;
=ObservationMethod;
|
- 46. immune receptor
- [cell surface molecules on cells of the immune system that specifically bind surface molecules or messenger molecules and trigger changes in the behavior of cells; although these receptors were first identified in the immune system, many have important functions elsewhere; not all immunologic receptors are tree'd under this term. ( CSP )] (UMLS (CSP) C0034817) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor =Cell Surface Receptor;
=Extracellular Matrix, Integrins;
scavenger receptor;
cytokine receptor | - 96. Immunofluorescent antibody, direct
- [Immune stain, Immunofluorescent antibody, direct ( HL7V3.0 )] (UMLS (HL7) C1553147) =Laboratory Procedure =ObservationMethod;
|
- 47. immune resistance
- [ ] (UMLS (CSP) C1328910) =Physiologic Function
| - 97. Immunofluorescent antibody, indirect
- [Immune stain, Immunofluorescent antibody, indirect ( HL7V3.0 )] (UMLS (HL7) C1553148) =Laboratory Procedure =ObservationMethod;
|
- 48. immune response gene
- [specific set of MHC genes whose protein products are involved in executing the immune response; genetic diversity underlies differences in immune responses between individuals. ( CSP )] (UMLS (CSP) C0086344) =Gene or Genome =structural gene;
immunogenetics | - 98. immunogenetics
- [subdiscipline of genetics (the branch of science concerned with the means and consequences of transmission and generation of the components of biological inheritance) which deals with the genetic basis of the immune response. ( CSP )] (UMLS (CSP) C0021005) =Biomedical Occupation or Discipline ;
=Genetics;
Immunology =DNA rearrangement;
immunoglobulin gene;
immune response gene;
histocompatibility gene |
- 49. immune serum bank
- [ ] (UMLS (CSP) C0597886) =Health Care Related Organization ;
| - 99. immunogenic
- [ ] (UMLS (CSP) C0872192) =Functional Concept ;
|
- 50. Immune Surveillance
- [Immune Surveillance refers to T cell circulation through tissues and destruction of virally infected cells (and possibly cancer cells) that induce T cell activation due to expression of foreign antigens. ( NCI )] (UMLS (NCI) C0021059) =Organism Function ;
| - 100. immunoglobulin allotype
- [Allelic variants of the immunoglobulin light chains (IMMUNOGLOBULIN LIGHT CHAINS) or heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) encoded by ALLELES of IMMUNOGLOBULIN GENES. ( MSH )] (UMLS (CSP) C0021006) =Immunologic Factor ;
|
home
